ICMR approaches experts panel to approve testing of cancer drug acalabrutinib for Covid treatment

ICMR ’s National AIDS Research Institute (NARI) had presented a proposal to the Subject Expert Committee (SEC) formed to review Covid related proposals seeking to amend Solidarity’s ongoing protocol by adding a trial arm to test acalabrutinib.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news